Companies

Seres Therapeutics, Inc.

MCRB · CIK 0001609809 · operating

$8.94+2.29%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$81.06M
P/E10.18
Fwd P/E-1.12
PEG
P/S230.93
P/B1.80
EV/EBITDA-1.20
EV/Rev338.10

Profitability

Gross Margin
Op. Margin
Net Margin
ROE0.99%
ROA0.10%
FCF Margin

Financial Health

Current Ratio0.94
Debt/Equity9.14
Free Cash Flow-$148.99M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth100.00%
Beta0.25
52W High$29.98
52W Low$6.53

About Seres Therapeutics, Inc.

Seres Therapeutics, Inc. (MCRB) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $80 million, Seres Therapeutics, Inc. is a micro-cap company. The stock currently trades at $8.94, up 2.29% today, with a 52-week range of $6.53–$29.98. The company trades at a trailing P/E of 10.1x.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$0.00$0.00+100.0%
2023$-0.89$-0.89+61.5%
2022$-2.31$-2.31
2021
2020
2019
2018
2017
2016
2015

Annual Reports (10-K) · 10 filings

Report DateFiledAccession Number
2024-12-312025-03-130000950170-25-038427SEC ↗
2023-12-312024-03-050000950170-24-025464SEC ↗
2022-12-312023-03-070000950170-23-006374SEC ↗
2021-12-312022-03-010000950170-22-002435SEC ↗
2020-12-312021-03-020001564590-21-010057SEC ↗
2019-12-312020-03-020001564590-20-008002SEC ↗
2018-12-312019-03-060001564590-19-006423SEC ↗
2017-12-312018-03-080001564590-18-004830SEC ↗
2016-12-312017-03-160001564590-17-004551SEC ↗
2015-12-312016-03-140001564590-16-014692SEC ↗